NCT04707677

Brief Summary

Objective: The aim of this randomized clinical trial was to compare ceramic and titanium implants with respect to the esthetic and clinical parameters, and patient reported outcome measures (PROMs). Material and methods: Thirty patients received thirty implants (8-12 mm in length, 3.3 mm diameter and a tissue level design) to replace the absence of a single tooth in the anterior maxilla. Patients were randomly allocated to receive a ceramic or a titanium implant. Esthetic and clinical parameters and PROMs were evaluated 18 months after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 13, 2021

Completed
Last Updated

December 27, 2021

Status Verified

February 1, 2021

Enrollment Period

1.8 years

First QC Date

January 10, 2021

Last Update Submit

December 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome was the Implant Crown Aesthetic Index (ICAI).

    It consists of nine sections: (i) mesiodistal dimension of the crown, (ii) position of the incisal edge of the crown, (iii) labial convexity of the crown, (iv) color and translucency of the crown, (v) crown surface, (vi) position of the gingival margin of the peri-implant mucosa, (vii) position of the interdental papilla, (viii) contour of the vestibular mucosa and (ix) color and surface of the vestibular mucosa. These sections were compared with the adjacent and contralateral tooth as a reference and assigned the following score: 0, excellent; 1 or 2 satisfactory; 3 or 4 moderate; 5 or more bad (Meijer et al., 2005).

    36 months

Study Arms (2)

CONTROL GROUP

ACTIVE COMPARATOR

Implant surgery placement. Tissue Level SLA Titanium implant (Straumann Standard Plus Narrow Neck CrossFit®; Institut Straumann, Basel, Switzerland). The implant had a diameter of 3.3 mm and a polished neck of 1.8 mm. The length of the implants was 8, 10 and 12 mm and was chosen according to the patient's anatomy.

Device: Titanium and ceramic dental Implants

TEST GROUP

EXPERIMENTAL

Implant surgery placement. Tissue Level Ceramic monotype implant was placed (Straumann PURE Ceramic implants®; Institut Straumann, Basel, Switzerland). The implant had a diameter of 3.3 mm and a polished neck of 1.8 mm. The length of the implants was 8, 10 and 12 mm and was chosen according to the patient's anatomy.

Device: Titanium and ceramic dental Implants

Interventions

Two types of implant placement and follow-up to compare the esthetic, clinical and radiographic parameters between them.

CONTROL GROUPTEST GROUP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontal and systemically healthy patients \> 18 years of age, with good plaque control (\< 25%).
  • Patients with a missing tooth in the anterior maxilla (from 13 to 23) with the presence of adjacent natural dentition mesially and distally (single gap). A minimum of 4 months of healing after tooth extraction was required before implant insertion.
  • Presence of ≥ 2mm of keratinized tissue.
  • Simultaneous bone regeneration was allowed during surgery.

You may not qualify if:

  • Intake any medication or presence of any systemic disease that could affect bone metabolism.
  • Pregnancy, or lactating women.
  • Active periodontal disease
  • Smoking \>10 cig/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Master Periodoncia

Santiago de Compostela, 15782, Spain

Location

Study Officials

  • Juan Blanco

    University of Santiago de Compostela

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two study groups, test (titanium implants) and control (ceramic implants)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctorate in Dentistry

Study Record Dates

First Submitted

January 10, 2021

First Posted

January 13, 2021

Study Start

September 15, 2015

Primary Completion

June 30, 2017

Study Completion

March 30, 2020

Last Updated

December 27, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations